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	 Two	new	and	simple	spectrophotometric	procedures	have	been	proposed	and	validated	for
estimation	 of	 two	 important	 macrolide	 antibiotics	 namely,	 azithromycin	 dihydrate	 and
roxithromycin.	Method	I	depends	on	complex	 formation	between	any	of	the	two	drugs	and
copper	in	acidic	medium	where	the	absorbances	of	the	produced	complexes	are	measured	at
250	and	264	nm	with	linearity	ranges	of	1.0‐100.0	and	2.0‐130.0	µg/mL	for	the	two	drugs,
respectively.	 Method	 II	 depends	 on	 the	 reaction	 of	 these	 drugs	 with	N‐bromosuccinimide
forming	 a	 product	 which	 is	 yellow	 colored,	 measured	 at	 264	 and	 278	 nm,	 with	 linearity
ranges	 of	 2.0‐140.0	 and	 3.0‐160.0	 µg/mL	 for	 azithromycin	 dihydrate	 and	 roxithromycin,
respectively.	 The	 proposed	 methods	 were	 subjected	 to	 detailed	 validation	 procedure;
moreover	they	were	used	for	the	estimation	of	the	concerned	drugs	in	their	different	dosage
forms.	 Study	 of	 the	 reactions	 stoichiometry	 was	 carried	 out;	 furthermore,	 a	 reaction
mechanism	proposal	was	presented.	
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1.	Introduction	
	
Azithromycin	 dihydrate	 (AZT)	 is	 a	 nitrogen‐containing	
macrolide.	It	is	chemically	known	as	(2R,3S,4R,5R,8R,10R,11R,	
12S,	 13S,	 14R)‐13‐[(2,	 6‐dideoxy‐3‐C‐methyl‐3‐o‐methyl‐a‐L‐
ribo‐hexopyranosyl)oxy]‐2‐ethyl‐3,	4,10‐trihydroxy‐3,5,6,8,10,	
12,	 14‐heptamethyl‐11‐[[3,4,6‐trideoxy‐3‐(dimethylamino)‐b‐
D‐xylo‐hexopyranosyl]oxy]	 ‐1‐oxa‐6‐azacyclopentadecan‐15‐
one	[1]	(Figure	1	(a)).	It	is	used	for	treating	respiratory‐tract,	
soft‐tissue	and	skin	infections.	It	is	also	used	in	case	of	typhoid	
and	trachoma	[2].	
Roxithromycin	 (ROX)	 is	 a	 macrolide	 antibiotic	 obtained	
from	erythromycin.	It	is	designated	chemically	as	(3R,4S,5S,6R,	
7R,9R,11S,12R,13S,14R)‐4‐[(2,	6‐dideoxy‐3‐C‐methyl‐3‐o‐meth	
yl‐a‐L‐ribo‐hexopyranosyl)oxy]‐14‐ethyl‐7,12,	 13‐trihydroxy‐
10‐[(E)‐[(2‐methoxyethoxy)methoxy]imino]‐3,	5,	 7,	 9,	 11,	13‐
hexamethyl‐6‐[[3,	 4,	 6‐trideoxy‐3‐(dimethylamino)‐b‐D‐xylo‐
hexopyranosyl]oxy]oxacyclotetradecan‐2‐one	 (Erythromycin	
9‐(E)‐[O‐[(2‐methoxyethoxy)methyl]oxime])	 [1]	 (Figure	 1	
(b)).	Its	uses	include	the	treatment	Legionella	infections.	When	
combined	 with	 neomycin,	 it	 is	 utilized	 for	 the	 counteractive	
action	of	surgical	infection	in	patients	having	gut	surgery	[2].		
	
Literature	 survey	 revealed	 different	 methods	 for	
estimation	 of	 AZT	 or	 ROX	 whether	 alone	 or	 in	 combination	
with	other	drugs.	As	for	AZT,	 it	has	been	determined	by	high	
performance	liquid	chromatography	(HPLC)	[3‐6],	liquid	chro‐
matography‐mass	 detection	 (LC‐MS/MS)	 [7,8],	 ultra‐perfor‐
mance	 liquid	 chromatography	 (UPLC)	 [9],	 micellar	 liquid	
chromatography	(MLC)	[10],	spectroflourimetry	[11]	and	UV‐
Visible	 spectrophotometry	 [12‐17]	 while	 ROX	 has	 been	 esti‐
mated	 by	 HPLC	 [18,19],	 LC‐MS/MS	 [20],	 spectroflourimetry	
[21,22]	and	UV‐Visible	spectrophotometry	[23].	
There	is	also	a	spectrophotometric	method	for	estimation	
of	AZT	and	ROX	that	was	performed	in	our	laboratory	for	their	
estimation	 in	 pharmaceutical	 preparations	 [24].	 Till	 now,	 no	
methods	 have	 been	 reported	 for	 spectrophotometric	 estima‐
tion	by	using	metal	 complexation	or	N‐bromosuccinimide	 for	
any	 of	 the	 two	 drugs	which	 encouraged	 us	 to	 develop	 these	
methods.	Spectrophotometry	is	a	very	important	technique	in	
drug	 analysis	 due	 to	 its	 availability	 in	 most	 laboratories,	
simplicity	 and	 low	 cost.	 The	developed	methods	have	 simple	
procedures	 and	 wider	 determination	 ranges,	 also	 they	 are	
rapid	 and	 convenient	 in	 comparison	 with	 the	 reported	
spectrophotometric	methods	[12‐14,23,24],	so	can	be	applied	
in	quality	control	laboratories	for	routine	analysis.	
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Table	1.	Assay	parameters	for	determination	of	AZT	and	ROX	by	Method	I	and	II.	
Method	 Assay	parameters	 AZT	 ROX	
I	 Volume	of	metal	ion	 2	mL 3	mL
Buffer	PH	 6	(borate	buffer) 5.5	(acetate	buffer)	
Volume	of	Buffer	solution	 2	mL	 1.5	mL	
λmax	 250	nm	 264	nm	
II	 Volume	of	NBS	 0.5	mL 1	mL
Heating	Temperature	 40	oC 50	oC
Heating	Time	 20	min. 20	min.	
Diluting	Solvent Methanol Methanol	
λmax	 264	nm	 278	nm	
	
	
	(a)	
	
																		(b)	
	
Figure	1.	Structural	formula	of	(a)	AZT	and	(b)	ROX.	
	
2.	Experimental	
	
2.1.	Instrumentations	
	
A	 double‐beam	 Shimadzu	 UV‐Vis	 spectrophotometer	
(Kyoto,	 Japan)	model	 UV	 1601	 PC	 (1.0	 cm	 quartz	 cells)	 was	
used	for	all	absorbance	measurements.	A	Jenway	3503	digital	
pH	meter	 (Stone,	 Staffs,	 UK)	was	 used	 for	 adjustment	 of	 the	
pH.	
	
2.2.	Materials	
	
Azithromycin	 dihydrate	 (Batch	No.1B07007)	 sample	was	
obtained	 from	 Amoun	 Pharmaceutical	 Co.,	 El‐Obour	 City,	
Cairo,	 Egypt.	 It	 is	 certified	 to	 have	 a	 potency	 of	 100.8%.	
Roxithromycin	 (Batch	No.	011006B)	 sample	was	supplied	by	
Alkan	Pharma	Co.,	 6th	 of	October	City,	Egypt.	 It	 is	 certified	 to	
have	 a	 potency	 of	 98%.	 Xithrone®	 tablets	 contain	 500	mg	 of	
Azithromycin/tablet	 (Batch	 No.	 153132)	 products	 of	 Amoun	
Pharma	Co.,	 Cairo,	 Egypt.	 Roxicin®	 tablets	 contain	150	mg	of	
ROX/tablet	(Batch	No.	101124)	products	of	El‐Obour	Modern	
Pharmaceutical	 industries	 Co.,	 Cairo,	 Egypt.	 Zithrocan®	
capsules	 labeled	 to	 contain	 524.06	 mg	 of	 Azithromycin	
dihydrate/tablet	(Batch	No.	131)	produced	by	Hikma	Pharma	
Co.,	6th	of	October	City,	Egypt.	Xithrone®	suspension	contains	
200	mg	Azithromycin/5	mL,	 (Batch	No.	155359),	products	of	
Amoun	 Pharma	 Co.,	 Cairo,	 Egypt.	 All	 dosage	 forms	 were	
obtained	from	municipal	pharmacy.	
	
2.3.	Reagents	and	Chemicals		
	
All	 reagents	 and	 chemicals	 were	 of	 analytical	 grade,	
solvents	were	of	spectroscopic	grade	and	the	water	utilized	in	
the	 study	was	 distilled.	 Aqueous	 solution	 of	 copper	 sulphate	
(CuSO4·5H2O),	 obtained	 from	 El	 Nasr	 Co.	 (ADWIC,	 Cairo,	
Egypt)	of	concentration	(5×10‐3	M),	acetate	buffer	solution	(0.2	
M)	 was	 obtained	 by	 adjusting	 the	 pH	 of	 sodium	 acetate	
trihydrate	 (0.2	M)	 with	 acetic	 acid	 (0.2	 M)	 [25],	 El	 Nasr	 Co.	
(ADWIC,	 Cairo,	 Egypt),	 borate	 buffer	 solution	 (0.2	 M)	 was	
obtained	by	adjusting	the	pH	of	boric	acid	(0.2	M)	with	NaOH	
(0.2	 M),	 El	 Nasr	 Co.	 (ADWIC,	 Cairo,	 Egypt)	 and	 N‐
bromosuccinimide	 (NBS)	 with	 purity	 98%,	 (0.056	 M)	 was	
freshly	 prepared	 in	 distilled	 water,	 Sisco	 Research	
Laboratories,	Mumbai,	India.	
	
2.4.	Standard	solution		
	
Stock	 solutions	 of	 AZT	 and	 ROX	 containing	 200.0	 µg/mL	
were	obtained	by	dissolving	20.0	mg	of	 the	pure	drug	 in	100	
mL	 of	methanol.	With	 the	 same	 solvent,	 further	dilution	was	
done	 to	 get	 the	 required	 concentration.	 The	 solution	 was	
stable	for	at	least	7	days	when	kept	in	the	refrigerator.		
	
2.5.	General	procedures	
	
2.5.1.	Construction	of	calibration	graphs		
	
2.5.1.1.	Method	Ι	
	
Accurate	volumes	of	AZT	and	ROX	standard	solutions	were	
measured	and	transferred	into	a	series	of	10.0	mL	volumetric	
flasks.	Borate	or	acetate	buffer	with	optimum	pH	were	added	
to	 each	 flask	with	 their	 specified	 volumes	 then	 the	 specified	
volume	of	copper	solution	was	added	(Table	1).	Distilled	water	
was	 used	 to	 complete	 solutions	 to	 the	mark	 and	 thoroughly	
mixed.	The	absorbance	of	each	solution	was	measured	at	 the	
specific	λmax	(Table	1)	against	a	reagent	blank.	The	absorbance	
values	 were	 plotted	 against	 drug	 concentrations	 (µg/mL)	 to	
get	 the	 calibration	 plots;	 alternatively	 the	 corresponding	
regression	equations	were	derived.	
	
2.5.1.2.	Method	ΙΙ	
	
Accurate	volumes	of	AZT	and	ROX	standard	solutions	were	
measured	 and	 transferred	 into	 a	 series	 of	 test	 tubes.	 The	
specified	volumes	of	NBS	were	added	to	each	test	tube	(Table	
1)	 then	 heated	 in	 water	 bath	 using	 the	 specified	 time	 and	
temperature	mentioned	in	Table	1.	After	cooling,	the	solutions	
were	 quantitatively	 transferred	 into	 a	 series	 of	 10.0	 mL	
volumetric	 flasks	 and	 completed	 to	 the	mark	with	methanol.	
The	solutions	were	 thoroughly	mixed.	The	absorbance	of	 the	
produced	 colored	 product	was	measured	 at	 the	 specific	 λmax	
(Table	 1)	 against	 blank	 solution.	 The	 calibration	 graph	 was	
obtained	by	same	steps	as	Method	I.	
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Table	2.	Analytical	performance	data	for	the	proposed	methods.	
Parameter	 Method	IA	 Method	IB Method	IIA Method	IIB	
Concentration	range	(µg/mL)	 1.0	‐100	 2.0‐130 2.0‐140 3.0‐160	
Limit	of	detection	LOD	(µg/mL)	 0.7604	 0.9050 0.6938 1.4696	
Limit	of	Quantitation	LOQ	(µg/mL)	 2.3043	 2.7425 2.1026 4.4533	
Regression	equation	*	y=a+bx	 y	=	0.0078x	+	0.0859 y =	0.0047x +	0.1268 y =	0.0106x +	0.093 y	=	0.0083x	+0.0317
Correlation	coefficient	 0.9999	 0.9999	 0.9998	 0.9999	
(Sy/x)	 0.0032	 0.0024	 0.0041	 0.0061	
(Sa)	 0.0018	 0.0013 0.0022 0.0037	
(Sb)	 0.0001	 0.0000	 0.0001	 0.0001	
%RSD	 0.553	 0.697	 0.596	 0.504	
%Error	(%RSD/√n)	 0.176	 0.220 0.188 0.159	
A%	(dl.g‐1.cm‐1)	 78.37	 46.99 105.76 82.55	
Molar	absorptivity	(L.mol.‐1cm‐1)	 6152.19	 3933.21 8302.49 6910.10	
*	y:	absorbance;	a:	intercept;	x:	Concentration	(µg/mL);	b:	slope.	
	
	
2.5.2.	Procedure	for	tablets	
	
Ten	tablets	were	accurately	weighed,	finely	pulverized	and	
thoroughly	 mixed.	 An	 accurately	 weighed	 amount	 of	 the	
powdered	 tablets	 equivalent	 to	 20.0	mg	 of	 AZT	 or	 ROX	was	
transferred	 into	a	100.0	mL	conical	 flask	and	about	40	mL	of	
methanol	 were	 added.	 The	 contents	 of	 the	 flask	 were	
sonicated	for	30	minutes,	filtered	into	100	mL	volumetric	flask	
and	 completed	 to	 the	mark	with	 the	 same	 solvent.	 Different	
aliquots	 of	 the	 filtrate	 were	 accurately	 transferred	 into	 10.0	
mL	 volumetric	 flasks.	 Then,	 proceed	 as	 described	 under	
“Construction	of	calibration	graphs	for	Method	I	and	II”.	From	
the	corresponding	regression	equations,	the	nominal	contents	
of	tablets	were	determined.		
	
2.5.3.	Procedure	for	capsules	
	
The	content	of	10	capsules	were	weighed	and	thoroughly	
mixed.	 A	weighed	 quantity	 of	 the	 powder	 equivalent	 to	 20.0	
mg	AZT	was	transferred	into	a	100.0	mL	volumetric	flask	and	
the	 volume	 was	 made	 up	 to	 the	 mark	 with	 methanol.	 The	
contents	 of	 the	 flask	were	 sonicated	 for	 30	minutes,	 filtered	
and	 different	 volumes	 of	 the	 filtrate	 were	 quantitatively	
transferred	into	10.0	mL	volumetric	flask.	The	procedure	was	
followed	 as	 described	 under	 “Construction	 of	 the	 calibration	
graph	for	Method	I	and	II”.	From	the	corresponding	regression	
equations,	 the	 nominal	 contents	 of	 the	 capsules	 were	
calculated.	
	
2.5.4.	Procedure	for	suspension	
	
An	 accurate	 volume	 of	 the	 freshly	 reconstituted	 oral	
suspension	 equivalent	 to	20.0	mg	of	AZT	was	 extracted	with	
about	25	mL	of	methanol,	sonicated	for	about	45	min,	left	for	a	
time	 in	 a	 refrigerator	 to	 allow	 any	 insoluble	matter	 to	 settle	
down	 then	 filtered	 into	 a	 100.0	 mL	 volumetric	 flask.	 The	
solution	was	 then	 completed	 to	 volume	with	methanol.	 This	
extract	was	further	diluted	with	methanol.	The	procedure	was	
completed	 as	 mentioned	 for	 preparing	 the	 calibration	 plots.	
From	 the	 corresponding	 regression	 equation,	 the	 nominal	
contents	of	the	suspension	were	determined.	
	
3.	Results	and	discussion	
	
3.1.	Method	I	
	
It	was	found	that	the	binary	complexes	of	AZT	or	ROX	with	
metal	 ions	 have	 not	 been	 studied	 yet.	 This	 encouraged	 us	 to	
develop	 this	 method.	 As	 they	 may	 have	 an	 effect	 on	 bio‐
availability	of	AZT	and	ROX	as	some	metal	ions	are	present	in	
relatively	 appreciable	 concentration	 in	 biological	 fluids.	 The	
absorption	spectra	of	AZT	in	borate	buffer	and	ROX	in	acetate	
buffer	of	optimum	pH	value	exhibits	maximum	absorbance	at	
219	 and	 198	 nm,	 respectively.	 Upon	 complexation	with	 Cu2+	
ions,	the	maximum	absorbances	were	obtained	at	250	and	264	
nm	 for	 AZT	 and	 ROX,	 respectively,	 as	 illustrated	 in	 Figure	 2	
and	3.	
	
	
	
Figure	2.	Absorption	spectra	of	(a)	AZT	(30.0	µg/mL)	in	methanol,	(b)	AZT	
(30.0	µg/mL)	 in	borate	buffer	of	pH	6	and	 (c)	AZT	 (30.0	µg/mL)	 complex	
with	copper	in	borate	buffer	of	pH	6.	
	
	
	
Figure	3.	Absorption	spectra	of	(a)	ROX	(30.0	µg/mL)	in	methanol,	(b)	ROX	
(30.0	µg/mL)	in	acetate	buffer	of	pH	5.5,	and	(c)	ROX	(30.0	µg/mL)	complex	
with	copper	in	acetate	buffer	of	pH	5.5.
	
3.1.1.	Optimization	of	experimental	conditions	
	
It	was	found	that	AZT	and	ROX	form	stable	complexes	with	
Cu2+.	The	experimental	conditions	influencing	the	formation	of	
complexes	and	their	stability	were	studied	and	optimized.		
	
3.1.2.	pH		
	
The	 influence	 of	 pH	 was	 observed	 over	 the	 pH	 range	 of	
2.5‐10.0.	It	was	found	that	optimum	pH	is	6.0	for	AZT,	and	5.5	
for	ROX.	
	
3.1.3.	Metal	ion	concentration	
	
The	 influence	 of	 copper	 ion	 concentration	 was	 studied	
using	 increasing	 volumes	 of	 Cu2+	 solution	 (5×10‐3	 M).	 It	 was	
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found	 that	 the	 optimum	volumes	 of	 Cu2+	 are	 2	 and	 3	mL	 for	
AZT	and	ROX,	respectively.	
	
3.1.4.	Buffer	volume	
	
The	effect	of	 the	buffer	volume	was	also	observed.	 It	was	
observed	that	2.0	mL	of	the	borate	buffer	and	1.5	mL	of	acetate	
buffer	 was	 used	 for	 maximum	 absorbance	 of	 AZT	 and	 ROX‐
copper	complexes,	respectively.	
	
3.1.5.	Temperature	
	
The	 influence	 of	 temperature	 was	 investigated.	 The	
maximum	absorbance	was	obtained	at	room	temperature	and	
decreased	 by	 increasing	 temperature.	 It	 was	 also	 found	 that	
the	complex	is	formed	instantaneously	and	is	stable	for	at	least	
two	hours.	
	
3.1.6.	Diluting	solvents	
	
The	 effect	 of	 diluting	 solvents	 on	 the	 absorbance	 of	 the	
produced	 complexes	 was	 studied	 including	 distilled	 water,	
methanol,	 acetonitrile,	 dimethylformamide	 and	 butanol.	
Distilled	water	was	found	to	be	the	best	diluting	solvent	giving	
the	maximum	 absorbance,	 which	 adds	 another	 advantage	 to	
the	proposed	method.	
	
3.1.7.	Order	of	addition	
	
The	 effect	 of	 order	 of	 addition	 of	 buffer	 solution	 and	
copper	 was	 also	 studied.	 It	 was	 found	 that	 the	 maximum	
absorbance	was	obtained	by	addition	of	buffer	solution	before	
copper	for	both	drugs.	
	
3.2.	Method	II	
	
N‐Bromosuccinimide	 is	 a	 very	 useful	 and	 important	
reagent	 [26].	 It	 has	 a	 strong	 brominating	 ability	 [27].	 It	 has	
been	 reported	 that	 tertiary	 amine	 reacts	 with	 N‐bromo‐
succinimide	 to	 produce	 colored	 intermediate,	 which	 on	
hydrolysis	 gives	 aldehydes	 and	brominated	 secondary	 amine	
whereas	 N‐bromosuccinimide	 is	 irreversibly	 reduced	 to	
succinimide	 [28].	 Since	 both	 AZT	 and	 ROX	 contain	 tertiary	
amino	groups,	they	are	susceptible	to	react	with	NBS	yielding	
a	 colored	 product	with	 λmax	 of	 264	 and	 278	nm	 for	AZT	 and	
ROX,	respectively,	as	presented	in	Figure	4‐5	[29].	
	
3.2.1.	Optimization	of	experimental	conditions	
	
The	 optimum	 conditions	 for	 the	 proposed	methods	 have	
been	 studied	 and	 optimized	 including:	 concentration	 of	NBS,	
heating	 temperature,	 heating	 time	 and	 nature	 of	 diluting	
solvent	(Table	1).	
	
3.2.2.	Concentration	of	NBS	
	
The	 impact	 of	 NBS	 concentration	 on	 the	 color	
development	 was	 studied	 using	 increasing	 volumes	 of	 NBS	
solution	(0.056	M)	from	0.2	to	3.0	mL.	The	highest	absorbance	
was	 obtained	with	 0.5	mL	 for	 AZT	 and	 1.0	mL	 for	 ROX	 that	
remained	unchanged	with	increasing	the	amount	of	NBS.	
	
3.2.3.	Heating	temperature	
	
The	 influence	 of	 heating	 temperature	 on	 the	 colored	
product	absorbance	was	observed	from	room	temperature	up	
to	boiling	temperature.	It	was	observed	that	40	and	50	°C	were	
the	optimum	temperature	giving	the	maximum	absorbance	for	
AZT	and	ROX,	respectively.	
	
	
	
	
Figure	 4.	 Absorption	 spectra	 of	 (a)	 AZT	 (60.0	 µg/mL)	 in	 methanol,	 (b)	
Reaction	product	of	AZT (60.0	µg/mL)	with	NBS.	
	
	
	
Figure	5.	Absorption	spectra	of	(a)	ROX	(60.0	µg/mL)	in	methanol	and	(b)	
Reaction	product	of	ROX	(60.0	µg/mL)	with	NBS.	
	
3.2.4.	Heating	time	
	
The	 influence	 of	 heating	 time	was	 also	 observed	 in	 from	
10‐60	minutes.	The	maximum	absorbance	was	obtained	after	
20	minutes	of	heating	at	optimum	temperature	in	case	of	both	
drugs.	
	
3.2.5.	Diluting	solvents	
	
The	 diluting	 solvents	 mentioned	 in	 Method	 I	 was	 also	
studied	 to	 select	 the	 appropriate	 one.	 Methanol	 is	 the	 best	
diluting	solvent	giving	the	maximum	absorbance	values.	
	
3.3.	Methods	validation 
	
The	 proposed	 procedures	 were	 validated	 according	 to	
ICHQ2	 (R1)	 recommendations	 [30],	 including	 the	 following	
validation	parameters.	
	
3.4.	Linearity	and	range	
	
The	calibration	plots	obtained	by	plotting	the	absorbance	
versus	 the	 final	 concentrations	 (µg/mL)	 were	 found	 to	 be	
linear	over	the	concentration	ranges	presented	in	Table	2.	The	
validity	 of	 the	 developed	methods	were	proven	 by	 statistical	
regression	line	[31]	and	it	was	found	that	percentage	relative	
standard	 deviation	 (%RSD)	 was	 small	 while	 correlation	
coefficient	values	 (r)	 	 approach	unity	 (Table	2)	 indicating	 the	
good	linearity	of	calibration	plots.	
	
3.5.	LOQ	and	LOD	
	
LOQ	 and	 LOD	 were	 determined	 using	 the	 following	
equations	[30]:	
 
LOQ	=	10×Sa/b	 	 	 	 	 (1)	
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Table	3.	Application	of	the	proposed	methods	to	the	determination	of	AZT	and	ROX	in	pure	form.	
Parameter	 Method	IA	 Method	IB	 Method	IIA	 Method	IIB	 Comparison	method	[24]	
Conc.	taken	
(µg/mL)	
%	Found	a	 Conc.	taken	
(µg/mL)	
%	Found	a Conc.
taken	
(µg/mL)	
%	Found	a Conc.
taken	
(µg/mL)	
%	Found	a	 %	Found	a	
for	ROX	
%	Found	a
for	AZT	
1.0	 100.00	 2.0	 99.05 2.0 99.06 3.0 99.60 100.4	 99.66
5.0	 100.13	 5.0	 99.00 5.0 100.94 5.0 99.42 99.35	 99.94
10.0	 99.42	 10.0	 99.15 10.0 100.47 10.0 100.80 100.5	 100.42
20.0	 100.04	 20.0	 99.04 20.0 99.53 20.0 99.06 100.0	 99.80
40.0	 100.67	 40.0	 100.43 40.0 99.43 40.0 99.14 	
50.0	 101.05	 80.0	 100.59 60.0 99.84 60.0 99.19
60.0	 101.30	 100.0	 100.68	 80.0	 99.29	 100.0	 99.23	
80.0	 100.02	 120.0	 99.86	 100.0	 99.72	 120.0	 99.68	
90.0	 100.30	 130.0	 99.27	 120.0	 100.39	 160.0	 99.34	
100.0	 100.53	 140.0 99.53
Mean±SD	 100.35±0.56	 99.72±0.70 99.82±0.60 99.51±0.50	 100.05±0.51	 99.96±0.33
t	 0.0519(2.262)	b	 0.7034(2.306)	b 0.383(2.262)	b 0.207(2.306)	b 	
F	 2.879(8.81)	b	 1.883(8.85)	b 3.305(8.81)	b 1.0404(8.85)	b
a	Each	result	is	the	average	of	three	separate	determinations.	
b	Values	between	brackets	are	the	tabulated	t	and	F	values,	at	p	=	0.05	[31].	
	
Table	4.	Precision	data	of	the	proposed	methods	for	the	determination	of	AZT	and	ROX	in	pure	form.	
Method	 Intra‐day	precision	 Inter‐day	precision	
Conc.	
taken	(µg/mL)	
Mean	|%found|±SD %RSD %Error Conc.	taken
(µg/mL)	
Mean	|%found|±SD	 %RSD	 %Error
IA	 40.0	 100.41±0.51	 0.50 0.29	 40.0	 100.01±0.46	 0.46	 0.27	
60.0	 100.48±0.62	 0.61	 0.31 60.0	 100.16±0.55	 0.55	 0.32	
80.0	 100.38±0.87	 0.87 0.50 80.0 100.19±0.44 0.44 0.25
IB	 40.0	 100.07±0.18	 0.18 0.10 40.0 99.46±0.55 0.55	 0.32
60.0	 99.91±0.69	 0.69 0.40 60.0 100.01±0.19 0.19	 0.11
80.0	 99.91±0.18	 0.18 0.10 80.0 99.99±0.34 0.34	 0.20
IIA	 40.0	 100.06±0.34	 0.34 0.20 40.0 100.18±0.25 0.25 0.15
60.0	 100.46±0.80 0.80 0.31 60.0 99.96±0.27 0.27	 0.15
80.0	 100.5±0.71	 0.71	 0.41	 80.0	 100.30±0.50 	 0.50	 0.29
IIB	 60.0	 100.46±0.43	 0.43	 0.31	 60.0	 100.04±0.33 0.33	 0.19	
80.0	 99.80±0.80	 0.80	 0.46	 80.0	 99.69±0.60	 0.60	 0.35	
100.0	 99.85±0.53 0.53 0.31 100.0 100.30±0.62 0.62	 0.36
	
	
LOD	=	3.3×Sa/b	 	 	 	 	 (2)	
		
These	data	are	outlined	in	Table	2.	
	
3.6.	Accuracy 
	
Statistical	 evaluation	 of	 the	 developed	 method	 using	
student	t‐test	and	the	variance	ratio	F‐test	[31]	demonstrated	
no	 significance	 differences	 between	 the	 performance	 of	 the	
proposed	and	comparison	methods	 [24]	 (Table	3).	 It	 is	 to	be	
mentioned	 that	 the	 comparison	 method	 [24]	 depends	 on	 a	
binary	 complex	 formation	 between	 the	 studied	 drugs	 and	
eosin	Y	in	aqueous	buffered	medium.	
	
3.7.	Precision 
	
Through	evaluating	 three	concentrations	of	AZT	and	ROX	
on	 three	 sequential	 time	 intervals,	 intraday	 precision	 was	
determined.	Furthermore,	repeated	analysis	of	three	concent‐
rations	for	three	successive	days,	allowed	interday	precision	to	
be	 demonstrated.	 Intraday	 and	 interday	 precision	 values	 are	
outlined	in	Table	4.	The	very	small	values	of	RSD	demonstrate	
the	 high	 repeatability	 and	 intermediate	 precision	 of	 the	
developed	procedures.	
	
3.8.	Robustness	 
	
It	 was	 established	 by	 the	 consistency	 of	 the	 absorbance	
with	 the	 deliberately	 small	 changes	 in	 the	 different	 experi‐
mental	conditions.	For	Method	I,	these	changes	include:	buffer	
volume	 (optimum	volume±0.5),	pH	 (optimum	pH±0.2),	metal	
ion	volume	(optimum	volume±0.2).	While	in	case	of	Method	II,	
these	 minor	 changes	 include:	 volume	 of	 NBS	 (optimum	
volume±0.2),	 heating	 temperature	 (optimum	 temperature±2	
°C),	 time	 of	 heating	 (optimum	 time±2	 minutes).These	 small	
changes	didn’t	influence	the	absorbance	value	obtained	by	the	
developed	 methods,	 demonstrating	 the	 robustness	 of	 these	
methods.	
	
3.9.	Specificity 
	
It	was	 demonstrated	 by	 investigation	 of	 any	 interference	
from	 the	 common	 tablet,	 capsule	 and	 suspension	 excipients.	
No	 interference	 was	 produced	 during	 the	 application	 of	 the	
developed	procedures.	
	 
3.10.	Pharmaceutical	applications	
	
The	 developed	 procedures	 were	 used	 to	 estimate	 the	
drugs	 in	 their	 dosage	 forms.	 The	 results	 obtained	 were	
statistically	compared	with	 those	of	a	 reference	method	 [24].	
No	 significant	 difference	 was	 found	 between	 the	 developed	
and	comparison	method	regarding	t	and	F	values as	shown	in	
Table	5.	
	
3.11.	Reactions	stoichiometry	and	mechanism 
	
Limiting	 logarithmic	 method	 [32]	 was	 used	 to	 study	 the	
reaction	 stoichiometry	 between	 AZT	 or	 ROX	 and	 copper	 or	
NBS.	 For	 Method	 I,	 curves	 of	 log	 absorbance	 versus	 either	
log[Cu2+]	or	log[Drug]	resulted	in	straight	lines	with	slopes	of	
0.7240/0.9384	for	AZT	and	0.7048/	0.7349	for	ROX	(Figure	6	
and	 7).	 So,	 it	 is	 demonstrated	 that	 the	 reaction	 take	 place	 in	
1:1	 ratio.	 A	 reaction	 mechanism	 proposal	 depending	 on	 the	
molar	reactivity	between	AZT	or	ROX	and	copper	is	presented	
in	 Scheme	 1	 and	 2.	 For	 method	 II,	 a	 similar	 approach	 was	
followed	where	 the	 slopes	were	 0.7258/0.8102	 for	 AZT	 and	
0.91964/	1.1949	for	ROX	(Figure	8	and	9)	 indicating	that	the	
reaction	 takes	 place	 in	 1:1	 ratio.	 The	 reaction	 mechanism	
proposal	presented	in	Scheme	3.	
	
	
	
	
208	 Ibrahim	et	al.	/	European	Journal	of	Chemistry	8	(3)	(2017)	203‐210	
	
	
Table	5.	Application	of	the	proposed	and	comparison	methods	to	the	determination	of	AZT	and	ROX	in	different	dosage	forms.	
Comparison	method	[24]Method	II Method	IConc.	taken	
(µg/mL)	
Pharmaceutical		
Preparation	 %	Found	a	%	Found	a%	Found	a	
99.04	100.18100.0020.0	Xithrone	tablets	
(500	mg	AZT/tablet)	 99.31	99.4098.1940.0	
101.77	
99.17	
‐	
100.09
101.50	
99.40	
102.32
100.36	
99.71	
60.0	
80.0	
100.0	
99.82±1.30	100.11±0.86100.12±1.48	Mean±SD	
‐ 0.598(2.776) b0.369(2.776) b t	
‐ 2.206(9.12) b1.688(9.12) b F	
99.34	100.9899.7720.0	Roxicin	tablets	
(150	mg	ROX/tablet)	 101.51	98.27100.1140.0	
99.12	
100.12	
‐	
100.23
98.94	
100.07	
101.59
99.26	
100.59	
60.0	
80.0	
100.0	
100.02±1.08	99.70±1.08	100.26±0.89	 Mean±SD	
‐ 0.511(2.776) b0.217(2.776) b t	
‐ 1.286(9.12) b1.165(9.12) b F	
101.49	99.69	99.86	20.0	Zithrocan	capsules	
(500	mg	AZT/capsule)	 99.31	100.41	99.21	40.0	
99.44	
100.40	
‐	
99.23	
99.14	
100.10	
100.27	
98.77	
99.88	
60.0	
80.0	
100.0	
100.16±1.01	99.71±0.5599.60±0.60	Mean±SD	
‐ 0.93(2.776)	b1.044(2.776)	b	 t	
‐ 3.033(9.12)	b	2.295(9.12)	b	 F	
99.35	99.9099.6720.0	Xithrone	suspension	
(200	mg	AZT/5	mL)	 99.79	98.91100.6640.0	
100.92	
99.57	
‐	
99.69	
100.16 
99.29	
99.16	
98.96 
100.15	
60.0	
80.0	
100.0	
99.91±0.70	99.59±0.5099.72±0.70	Mean±SD	
‐ 0.55(2.776) b0.571(2.776) b t	
 1.681(9.12)	b	1.183(9.12)	b		 F	
a	Each	result	is	the	average	of	three	separate	determinations.	
b	Values	between	brackets	are	the	tabulated	t	and	F	values,	at	p	=	0.05	[31].	
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Figure	6.	Limiting	logarithmic	plots	for	the	molar	reactivity	of	AZT	with	Cu2+.	
	
	
	
					 	
	
Figure	7.	Limiting	logarithmic	plots	for	the	molar	reactivity	of	ROX	with	Cu2+.
	
210	 Ibrahim	et	al.	/	European	Journal	of	Chemistry	8	(3)	(2017)	203‐210	
	
					 	
	
Figure	8.	Limiting	logarithmic	plots	for	the	molar	reactivity	of	AZT	with	NBS.
	
	
					 	
	
Figure	9.	Limiting	logarithmic	plots	for	the	molar	reactivity	of	ROX	with	NBS.
	
	
4.	Conclusion	
 
Two	 simple,	 sensitive,	 specific	 and	 inexpensive	 spectro‐
photometric	 procedures	 are	 proposed	 for	 estimation	 of	 AZT	
and	 ROX	 in	 their	 dosage	 forms	 with	 no	 interference	 from	
common	 excipients.	 Furthermore,	 the	 developed	 procedures	
are	rapid	and	do	not	need	complexed	requirements	needed	in	
chromatographic	methods.	In	addition,	they	offer	reproducible	
results	 and	 have	 the	 advantage	 of	 being	 simple	 and	
convenient.	So,	they	can	be	used	in	quality	control	laboratories	
for	routine	analysis.	
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